We will send letters next month to our members with commercial and Medicare Advantage plans letting them know about 2020 changes to ConnectiCare formularies.
These letters will include drugs that you may have prescribed. The changes, effective Jan. 1, 2020, may include updates to preauthorization or step therapy requirements, quantity limits, tier changes or formulary status.
Ask your patients if they received a letter and talk to them about the changes. If your patient needs to stay on the current therapy, please reach out to our Pharmacy Services department to request an exception before Jan. 1, 2020. For your Medicare Advantage patients, call 1-877-224-8230. For patients with commercial plans, call 1-800-828-3407.
